Scarica l'app Stockscreener
10.21
0.39%
0.04
Dopo l'orario di chiusura:
9.91
-0.30
-2.94%
Immunome Inc Borsa (IMNM) Ultime notizie
Short Interest in Immunome, Inc. (NASDAQ:IMNM) Grows By 12.2% - MarketBeat
Immunome (NASDAQ:IMNM) Shares Gap UpShould You Buy? - MarketBeat
Immunome, Inc. (NASDAQ:IMNM) Receives $28.83 Consensus PT from Brokerages - MarketBeat
Immunome, Inc. (NASDAQ:IMNM) Given Consensus Rating of “Buy” by Analysts - Defense World
Immunome (NASDAQ:IMNM) Stock Price Down 7.1%Here's Why - MarketBeat
Immunome’s (IMNM) Outperform Rating Reaffirmed at Wedbush - Defense World
Immunome (NASDAQ:IMNM) Given "Outperform" Rating at Wedbush - MarketBeat
Immunome (NASDAQ:IMNM) Sees Unusually-High Trading VolumeTime to Buy? - MarketBeat
Immunome Provides Pipeline Update in Advance of Presentation at the 43rd Annual J.P. Morgan Healthcare Conference - BioSpace
Immunome Provides Pipeline Update in Advance of Presentation at the 43 - Business Wire
Immunome, Inc. (NASDAQ:IMNM) Shares Purchased by Barclays PLC - Defense World
Head to Head Comparison: Oculis (NASDAQ:OCS) vs. Immunome (NASDAQ:IMNM) - Defense World
Head to Head Analysis: Immunome (NASDAQ:IMNM) vs. Bicara Therapeutics (NASDAQ:BCAX) - Defense World
Hummingbird Bioscience Licenses Novel Antibodies to Immunome - The Korea Bizwire
When the Price of (IMNM) Talks, People Listen - Stock Traders Daily
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Immunome Awards Stock Options to Key New Hires in Strategic Talent Acquisition Move - StockTitan
Immunome, Inc. (NASDAQ:IMNM) Sees Significant Drop in Short Interest - MarketBeat
Geode Capital Management LLC Has $17.66 Million Stake in Immunome, Inc. (NASDAQ:IMNM) - Defense World
Geode Capital Management LLC Increases Stock Holdings in Immunome, Inc. (NASDAQ:IMNM) - MarketBeat
Barclays PLC Boosts Holdings in Immunome, Inc. (NASDAQ:IMNM) - MarketBeat
Immunome (NASDAQ:IMNM) Shares Down 5.7%Time to Sell? - MarketBeat
State Street Corp Sells 176,768 Shares of Immunome, Inc. (NASDAQ:IMNM) - Defense World
State Street Corp Cuts Stock Position in Immunome, Inc. (NASDAQ:IMNM) - MarketBeat
Immunome, Inc. (NASDAQ:IMNM) Receives Average Rating of “Buy” from Analysts - Defense World
Immunome, Inc. (NASDAQ:IMNM) Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World
Immunome, Inc. (NASDAQ:IMNM) Receives Average Rating of "Buy" from Analysts - MarketBeat
Immunome, Inc. (NASDAQ:IMNM) Shares Acquired by Wellington Management Group LLP - Defense World
Wellington Management Group LLP Has $2.06 Million Stock Holdings in Immunome, Inc. (NASDAQ:IMNM) - MarketBeat
Immunome, Inc. (NASDAQ:IMNM) Sees Significant Decrease in Short Interest - Defense World
Immunome, Inc. (NASDAQ:IMNM) Short Interest Update - MarketBeat
Long Term Trading Analysis for (IMNM) - Stock Traders Daily
Immunome, Inc. (NASDAQ:IMNM) Position Lifted by Charles Schwab Investment Management Inc. - Defense World
Charles Schwab Investment Management Inc. Grows Position in Immunome, Inc. (NASDAQ:IMNM) - MarketBeat
Immunome: A Recently Acquired Lead Asset And A Small Market (NASDAQ:IMNM) - Seeking Alpha
The Manufacturers Life Insurance Company Sells 1,437 Shares of Immunome, Inc. (NASDAQ:IMNM) - Defense World
Point72 Asset Management L.P. Boosts Stock Holdings in Immunome, Inc. (NASDAQ:IMNM) - MarketBeat
Intech Investment Management LLC Takes $219,000 Position in Immunome, Inc. (NASDAQ:IMNM) - Defense World
Janus Henderson Group PLC Purchases 324,614 Shares of Immunome, Inc. (NASDAQ:IMNM) - MarketBeat
Cerity Partners LLC Has $776,000 Holdings in Immunome, Inc. (NASDAQ:IMNM) - Defense World
Where are the Opportunities in (IMNM) - Stock Traders Daily
Immunome Grants Stock Options to 15 New Hires in Workforce Expansion - StockTitan
Immunome to Present at the Piper Sandler 36th Annual Healthcare Conference - The Bakersfield Californian
President of Immunome Picks Up 24% More Stock - Simply Wall St
Why Is Immunome Inc (NASDAQ: IMNM) Gaining? - Stocks Register
Immunome, Inc. (NASDAQ:IMNM) Given Consensus Rating of "Buy" by Analysts - MarketBeat
Immunome (NASDAQ:IMNM) Shares Gap Up on Insider Buying Activity - Defense World
Immunome's chief medical officer Robert Lechleider buys $149,799 in stock - Investing.com India
Immunome's chief medical officer Robert Lechleider buys $149,799 in stock By Investing.com - Investing.com Australia
Immunome Inc (IMNM) CEO Clay Siegall Increases Stake with Signif - GuruFocus.com
Insider Buying: Robert Lechleider Acquires Shares of Immunome In - GuruFocus.com
Immunome, Inc. (NASDAQ:IMNM) CTO Acquires $198,030.00 in Stock - MarketBeat
Insider Buying: Immunome, Inc. (NASDAQ:IMNM) CEO Purchases 66,057 Shares of Stock - MarketBeat
1.44%
7.27%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):